Fig. 37From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseCoumarin alkylamines C41a–C41h (entry 1–8)Back to article page
